Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 12-O-tetradecanoylphorbol-13-acetate and 17β-estradiol on estrogen receptor regulation in MCF-7 human breast cancer cells

Journal of Cellular Biochemistry

Volumn 60, Issue 2, 1996, Pages 173-184

  Gierthy, John F ^a   Spink, Barbara C ^a   Figge, Helen L ^b   Pentecost, Brian T ^a   Spink, David C ^a  

^a WADSWORTH CENTER   (United States)

^b ALBANY MEDICAL CENTER   (United States)

Author keywords

Endocrine modulating; Environmental; Estrogen metabolism; Occupied nuclear estrogen receptors; P450

Indexed keywords

MINK CELL FOCUS-FORMING VIRUS;

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ALPHA NAPHTHOFLAVONE; CYTOCHROME P450; ESTRADIOL; ESTROGEN RECEPTOR; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; RIBONUCLEASE;

ARTICLE; BINDING COMPETITION; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ASSAY; ESTROGEN ACTIVITY; GENE EXPRESSION REGULATION; GENE REPRESSION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIGAND BINDING; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

BREAST NEOPLASMS; CARCINOGENS; ESTRADIOL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; RECEPTORS, ESTROGEN; RNA, MESSENGER; TETRACHLORODIBENZODIOXIN; TETRADECANOYLPHORBOL ACETATE;

EID: 0030023543     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19960201)60:2<173::AID-JCB2>3.0.CO;2-U     Document Type: Article

References (42)

1. Ausubel FM, Brent K, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds.) (1987): "Current Protocols in Molecular Biology." New York: John Wiley & Sons.
2. Birnbaum LS (1994): The mechanism of dioxin toxicity: Relationship to risk assessment. Environ Health Perspect 102(Suppl 9):157-167.
3. Borras M, Hardy L, Lempereur F, Khissiin AH, Legros N, Gol-Winkler R, Leclercq G (1994): Estradiol-induced down regulation of estrogen receptor. Effects of various modulators of protein synthesis and expression. J Steroid Biochem Mol Biol 48:325-336.
4. Cho H, Ng PA, Katzenellenbogen BS (1991): Differential regulation of gene expression by estrogen in estrogen growth-independent and -dependent MCF-7 human breast cancer cell sublines. Mol Endocrinol 5:1323-1330.
5. Chomcynski P, Sacchi N (1987): Single-step method of RNA isolation by acid guanidinium thioeyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
6. Colella TA, Gallo MA (1993): Down-regulation of hepatic estrogen receptor mRNA in 2,3,7,8-TCDD treated CD-I mice. The Toxicol 13:102.
7. Couture LA, Abbot BDE, Birnbaum LS (1990): A critical review of the developmental toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: Recent advances toward understanding the mechanism. Teratology 45:619-627.
8. DeVito MJ, Thomas T, Martin E, Umbreit TH, Gallo MA (1992): Antiestrogenic action of 2,3,7,8-tetrachlorodibenzo-p-dioxin: Tissue-specific regulation of estrogen receptor in CD 1 mice. Toxicol Appl Pharmacol II 3:284-292.
9. Fotis T, Zhang Y, Pepper MS, Alderereutz H, Montesano R, Nawroth PP, Schweigerer L (1994): The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumor growth. Nature 368:237-239.
10. Gallo NM, Heese EJ, MacDonald GJ, and Umbreit TH (1986): Interactive effects of estradiol and 2,3,7,8-tetrachlorodibenzo-p-dioxin on hepatic P-450 and mouse uterus. Toxicol Lett 32:123-132.
11. Gierthy JF, Lincoln DW, Gillespie MB, Seeger JI, Martinez HL, Dickerman HW, Kumar SA (1987): Suppression of estrogen-regulated extracellular tissue plasminogen activator activity of MCF-7 cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res 47:6198-6203.
12. Gierthy JF, Lincoln DW, Roth KE, Bowser SS, Bennett JA, Bradley L, Dickerman HW (1991): Estrogen-stimulation of postconfluent cell accumulation and foci formation of human MCF-7 breast cancer cells. J Cell Biochem 45:177-187.
13. Graham MJ, Lucier GW, Linko P, Maronpot RR, Goldstein JA (1988): Increases in P-450 mediated 17β-estradiol 2-hydroxylase activity in rat liver microsomes after both acute administration and subchronic administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin in a two stage hepatocarcinogenesis model. Carcinogenesis 9:1935-1941.
14. Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J (1986): Sequence and expression of human estrogen receptor complementary DNA. Science 231:1150-1154.
15. Harris M, Zacharewski T, Safe S (1990): Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds on the occupied nuclear estrogen receptor in MCF-7 breast cancer cells. Cancer Res 50:3579-3584.
16. Horwitz K, McGuire WL (1980): Nuclear estrogen receptors. Effects of inhibitors on processing and steady state levels. J Biol Chem 255:9699-9705.
17. 1-450: Complementary DNA and amino acid sequence. Science 228:80-83.
18. Kedderis LB, Diliberto JJ, Linko P, Goldstein JA, Birnbaum LS (1991): Disposition of 2,3,7,8-tetrabromodibenzo-p-dioxin and 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat: biliary excretion and induction of cytochromes CYPIA1 and CYPIA2. Toxicol Appl Pharmacol 111:163-172.
19. Lin FH, Stohs SJ, Birnbaum LS, Clark G, Lucier GW, Goldstein JA (1991): The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on hepatic estrogen and glucocorticoid receptors in congenic strains of Ah responsive and Ah nonresponsive C57BL/6J mice. Toxicol Appl Pharmacol 108:129-139.
20. Lottering ML, Haag M, Seegers JC (1992): Effects of 17β-estradiol metabolites on cell cycle events on MCF-7 cells. Cancer Res 52:5926-5932.
21. Lu Y, Wang X, Safe S (1994): Interaction of 2,3,7,8-tetrachlorodibenzo-p-dioxin and retinoic acid in MCF-7 human breast cancer cells. Toxicol Appl Pharmacol 127:1-8.
22. Masiakowski P, Breathnach R, Block J, Gannon F, Krust A, Chambon P (1982): Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 breast cancer cell line. Nucleic Acids Res 10:7895-7903.
23. Merchant M, Arellano L, Safe S (1990): The mechanism of action of α-naphthoflavone as an inhibitor of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYPIAI gene expression. Arch Biochem Biophys 281.84-89.
24. Murdoch FE, Gorski J (1991): The role of ligand in estrogen receptor regulation of gene expression. Mol Cell Endocrinol 78:C103-C108.
25. Namkung MJ, Porubek DJ, Nelson SD, Juchau MR (1985): Regulation of aromatic oxidation of estradiol-17β in maternal hepatic, fetal hepatic and placental tissues: comparative effects of a series of inducing agents. J Steroid Biochem 22:563-567.
26. Pasqualini JR, Gelly C, Lecerf F (1986): Biological effects and morphological responses to estriol, estriol-3-sulfate, estriol-I 7-sulfate and tamoxifen in a tamoxifen-resistant cell line (R-27) derived from MCF-7 human breast cancer cells. Eur J Cancer Clin Oncol 22:1495-1501.
27. Ree AH, Landmark BF, Walaas SI, Lahooti H, Eikvar L, Eskild W, Hansson V (1991): Down regulation of messenger ribonucleic acid and protein levels for estrogen receptors by phorbol ester and calcium in MCF-7 cells. Endocrinology 128:339-344.
28. Romkes M, Piskorska-Pliszczynska J, Safe S (1987): Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on hepatic and uterine estrogen receptor levels in rats. Toxicol Appl Pharmacol 87:6198-6203.
29. Saceda M, Lippman ME, Chambon P, Lindsey RL, Ponglikitmogkol M, Puente M, Martin MB (1988): Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol Endocrinol 2:1157-1162
30. Saceda M, Knabbe C, Dickson RB, Lippman ME, Bronzert D, Lindsey RK, Gottardis MM, Martin MB (1991): Post-transcriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-0-tetradecanoylphorbol-13-acetate. J Biol Chem 266:17809-17814.
31. Safe S, Astroff B, Harris M, Zacharewski T, Dickerson R, Romkes M, Biegel L (1991): 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related compounds as antiestrogens: Characterization and mechanism of action. Pharmacol Toxicol 69:400-409.
32. Shupnik MA, Gordon MS, Chin WW (1989): Tissue-specific regulation of rat estrogen receptor mRNAs. Mol Endocrinol 3:660-665.
33. Spink DC, Lincoln DW, Dickerman HW, Gierthy JF (1990): 2,3,7,8-tetrachlorodibenzo-p-dioxin causes an extensive alteration of 17β-estradiol metabolism in MCF-7 breast tumor cells. Proc Natl Acad Sci USA 87:6917-6921.
34. Spink DC, Eugster H-P, Lincoln DW, Schuetz JD, Schuetz EG, Johnson JA, Kaminsky LS, Gierthy JF (1992a): 17β-Estradiol hydroxylation catalyzed by human P4501A1: a comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA. Arch Biochem Biophys 293:342-348.
35. Spink DC, Lincoln DW, Johnson JA, Dickerman HW, Gierthy JF (1992b): Stimulation of 17β-estradiol metabolism by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Chemosphere 25:87-90.
36. Spink DC, Johnson JA, Connor SP, Aldous KM, Gierthy JF (1994a): Stimulation of 17β-estradiol metabolism in MCF-7 cells by bromochloro- and chloromethyl-substituted dibenzo-p-dioxins and dibenzofurans: Correlations with antiestrogenic activity. J Toxicol Environ Health 41:451-466.
37. Spink DC, Hayes CL, Young NR, Christou M, Sutter TR, Jefcoate CR, Gierthy JF (1994b): The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estrogen metabolism in MCF-7 breast cancer cells: evidence for induction of a novel 17β-estradiol 4-hydroxylase. J Steroid Biochem Mol Biol 51:251-258.
38. Tzukerman M, Zhang X-K, Pfahl M (1991): Inhibition of estrogen receptor activity by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate: A molecular analysis. Mol Endocrinol 5:1983-1992.
39. Umbreit TH, Hesse EJ, MacDonald GJ, Gallo MA (1988): Effects of TCDD-estradiol interactions in three strains of mice. Toxicol Lett 40:1-9.
40. Umbreit TH, Gallo MA (1988): Physiological implications of estrogen receptor modulation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Lett 42:5-14.
41. Umbreit TH, Scala PL, MacKenzie SA, Gallo MA (1989): Alteration of acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) by estradiol and tamoxifen. Toxicology 59:163-169
42. Wang X, Porter W, Krishnan V, Narasimhan TR, Safe S (1993): Mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated decrease of the nuclear estrogen receptor in MCF-7 human breast cancer cells. Mol Cell Endocrinol 96:159-166.